The IL-1 System in Psoriatic Skin IL-1 Antagonist Sphere of Influence in Lesional Psoriatic Epidermis

Journal of Immunology

Volumn 158, Issue 6, 1997, Pages 2955-2963

  Debets, Reno ^a   Hegmans, Joost P J J ^a   Croughs, Paul ^a   Troost, Roger J J ^b   Prins, Jan Bas ^a   Benner, Robbert ^a   Prens, Errol P ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IL1RN PROTEIN, HUMAN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1 RECEPTOR TYPE II; MESSENGER RNA; SIALOGLYCOPROTEIN;

ARTICLE; BIOSYNTHESIS; DRUG ANTAGONISM; EPIDERMIS; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PSORIASIS;

EPIDERMIS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; PSORIASIS; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE II; RNA, MESSENGER; SIALOGLYCOPROTEINS;

EID: 0031569196     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Hauser, C., J.-H. Saurat, A. Schmitt, F. Jaunin, and J.-M. Dayer. 1986. Interleukin 1 is present in normal human epidermis. J. Immunol. 136:3317.
2. Kupper, T. S., F. Lee, N. Birchall, S. Clark, and S. K. Dower. 1988. Interleukin 1 binds to specific receptors on human keratinocytes and induces granulocyte macrophage colony-stimulating factor mRNA and protein. J. Clin. Invest. 82: 1787.
3. Camp, R. D. R., N. J. Fincham, J. Ross, C. R. Bird, and A. J. H. Gearing. 1990. Potent inflammatory properties in human skin of interleukin-1 alpha-like material isolated from normal skin. J. Invest. Dermatol. 94:735.
4. Kupper, T. S. 1990. Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J. Clin. Invest. 86:1783.
5. Ristow, H. J. 1987. A major factor contributing to epidermal proliferation in inflammatory skin diseases appears to be interleukin 1 or a related protein. Proc. Natl. Acad. Sci. USA 84:1940.
6. McGuire, J., L. Didierjean, R. C. Langdon, J.-M. Dayer, and J.-H. Saurat. 1988. The subcellular distribution of different molecular weight forms of interleukin-1 alpha and beta in the human keratinocyte. J. Invest. Dermatol. 90:587 (Abstr.).
7. Mosley, B., D. L. Urdal, K. Prickett, A. Larsen, D. Cosman, P. J. Conlan, S. Gillis, and S. K. Dower. 1987. The interleukin-1 receptor binds the human interleukin-1α precursor but not the interleukin-1β precursor. J. Biol. Chem. 262: 2941.
8. Mizutani, H., R. Black, and T. S. Kupper. 1989. Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta: different strategies of IL-1 production and processing in monocytes and keratinocytes. J. Clin. Invest. 87:1066.
9. Eisenberg, S. P., R. J. Evan, W. P. Arend, E. Verderber, M. T. Brewer, C. H. Hannum, and R. C. Thompson. 1990. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341.
10. Haskill, S., G. Martin, L. Van Le, J. Morris, A. Peace, C. F. Bigler, G. J. Jaffe, C. Hammerberg, S. A. Sporn, S. Fong, W. P. Arend, and P. Ralph. 1991. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc. Natl. Acad. Sci. USA 88:3681.
11. Muzio, M., N. Polentarutti, M. Sironi, G. Poli, L. De Gioia, M. Introna, A. Mantovani, and F. Colotta. 1995. Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist. J. Exp. Med. 182:623.
12. Curtis, B. M., M. B. Widmer, P. De Roos, and E. E. Qwarnstrom. 1990. IL-1 and its receptor are translocated to the nucleus. J. Immunol. 144:1295.
13. Watson, J. M., A. K. Lofquist, C. A. Rinehart, J. C. Olsen, S. S. Makarov, D. G. Kaufman, and J. S. Haskill. 1995. The intracellular IL-1 receptor antagonist alters IL-1-inducible gene expression without blocking exogenous signaling by IL-1β. J. Immunol. 155:4467.
14. Sims, J., C. J. March, D. Cosman, M. B. Widmer, H. R. MacDonald, C. McMahan, C. E. Grubin, J. M. Wignall, J. Jackson, S. M. Call, D. Friend, A. Alpert, S. Gillis, D. L. Urdal, and S. Dower. 1988. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241:185.
15. McMahan, C., J. Slack, B. Mosley, D. Cosman, S. D. Lupton, L. L. Brunton, C. E. Grubin, J. M. Wignall, N. A. Jenkins, C. I. Brannan, N. G. Copeland, K. Huebner, C. M. Croce, L. A. Cannizzarro, D. Benjamin, S. Dower, M. Spriggs, and J. Sims. 1991. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10:2821.
16. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J. G. Giri, S. K. Dower, J. E. Sims, and A. Mantovani. 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472.
17. Sims, J., and S. Dower. 1994. Interleukin-1 receptors. Eur. Cytokine Netw. 5:539.
18. Groves, R. W., J. Giri, J. Sims, S. Dower, and T. S. Kupper. 1995. Inducible expression of type 2 IL-1 receptors by cultured human keratinocytes. Implications for IL-1-mediated processes in epidermis. J. Immunol. 154:4065.
19. Symons, J. A., J. A. Eastgate, and G. W. Duff. 1991. Purification and characterization of a novel soluble receptor for interleukin 1. J. Exp. Med. 174:1251.
20. Groves, R. W., H. Mizutani, J. D. Kieffer, and T. S. Kupper. 1995. Inflammatory skin disease in transgenic mice that express high levels of interleukin 1α in basal epidermis. Proc. Natl. Acad. Sci. USA 92:11874.
21. Cooper, K. D., C. Hammerberg, O. Baadsgaard, J. T. Elder, L. S. Chan, D. N. Sauder, J. J. Voorhees, and G. Fisher. 1990. IL-1 activity is reduced in psoriatic skin: decreased IL-1α and increased nonfunctional IL-1β. J. Immunol. 144:4593.
22. Gruaz, D., L. Didierjean, J. Grassi, Y. Frobert, J.-M. Dayer, and J.-H. Saurat. 1989. Interleukin 1 alpha and beta in psoriatic skin: enzymoimmunoassay, immunoblot studies and etfect of systemic retinoids. Dermatologica 179:202.
23. Gearing, A. J. H., N. J. Fincham, C. R. Bird, M. Wadhwa, A. Meager, J. E. Cartwright, and R. D. R. Camp. 1990. Cytokines in skin lesions of psoriasis. Cytokine 2:68.
24. Takematsu, H., Y. Ohmoto, and H. Tagami. 1990. Decreased levels of IL-1 alpha and beta in psoriatic lesional skin. Tohoku J. Exp. Med. 161:159.
25. Prens, E. P., K. Benne, J. Van Damme, M. Bakkus, K. Brakel, R. Benner, and T. Van Joost. 1990. Interleukin-1 and interleukin-6 in psoriasis. J. Invest. Dermatol. 95:121S.
26. Terui, T., R. Suzuki, K. Kumagai, H. Takematsu, T. Kato, and H. Tagami. 1988. Absence of IL-1 inhibitor in psoriatic scale extracts. Tohoku J. Exp. Med. 156: 149.
27. Hammerberg, C., W. P. Arend, G. J. Fisher, L. S. Chan, A. E. Berger, S. J. Haskill, J. J. Voorhees, and K. D. Cooper. 1992. Interleukin-1 receptor antagonist in normal and psoriatic epidermis. J. Clin. Invest. 90:571.
28. Didierjean, L., D. Salomon, Y. Mérot, G. Siegenthaler, A. Shaw, J.-M. Dayer, and J-H. Saurat. 1989. Localization and characterization of the interleukin 1 immunoreactive pool (IL-1 alpha and beta forms) in normal human epidermis. J. Invest. Dermatol. 92:809.
29. Tron, V. A., D. Rosenthal, and D. N. Sauder. 1988. Epidermal interleukin-1 is increased in cutaneous T-cell lymphoma. J. Invest. Dermatol. 90:178.
30. Romero, L. I., T. Ikejima, and S. H. Pincus. 1989. In situ localization of interleukin-1 in normal and psoriatic skin. J. Invest. Dermatol. 93:518.
31. Kristensen, M., B. Deleuran, D. J. Eedy, M. Feldmann, S. M. Breathnach, and F. M. Brennan. 1992. Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1α in normal and psoriatic skin: decreased expression of IRAP in psoriatic lesional epidermis. Br. J. Dermatol. 127:305.
32. Debets, R., J. P. J. J. Hegmans, R. J. J. Troost, R. Benner, and E. P. Prens. 1995. Enhanced production of biologically active interleukin-1α and interleukin-1β by psoriatic epidermal cells ex vivo: evidence of increased cytosolic interleukin-1β levels and facilitated interleukin-1 release. Eur. J. Immunol. 25:1624.
33. Longley, J., T. Gang Ding, C. Cuono, F. Durden, C. Crooks, S. Hufeisen, R. Eckert, and G. S. Wood. 1991. Isolation, detection, and amplification of intact mRNA from dermatome strips, epidermal sheets, and sorted epidermal cells. J. Invest. Dermatol. 97:974.
34. Fredriksson, T., and U. Pettersson. 1978. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 157:238.
35. Griffiths, C. E. M., J. N. W. N. Barker, S. Kunkel, and B. J. Nickoloff. 1991. Modulation of leucocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-α) in allergic contact dermatitis (Rhus dermatitis). Br. J. Dermatol. 124:519.
36. Cox, K. H., D. V. De Leon, L. M. Angerer, and R. C. Angerer. 1984. Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev. Biol. 101:485.
37. Angerer, L. M., and R. C. Angerer. 1991. Localization of mRNAs by in situ hybridization. In Methods in Cell Biology. Functional Organization of the Nucleus: A Laboratory Guide. B. A. Hamkalo and V. C. R. Elgin, eds. Academic Press, New York, p. 37.
38. De Block, M., and D. Debrouwer. 1993. RNA-RNA in situ hybridization using digoxigenin-labeled probes: the use of high-molecular-weight polyvinyl alcohol in the alkaline phosphatase indoxyl-nitroblue tetrazolium reaction. Anal. Biochem. 215:86.
39. Chomczynski, P., and N. Sacchi. 1987. Single-step method for RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
40. Krug, M. S., and S. L. Berger. 1987. First strand cDNA synthesis primed with oligo-d(T). Methods Enzymol. 152:316.
41. De Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. De Vries. 1991. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
42. Groves, R. W., L. Sherman, H. Mizutani, S. K. Dower, and T. S. Kupper. 1994. Detection of interleukin-1 receptors in human epidermis: induction of the type II receptor after organ culture and in psoriasis. Am. J. Pathol. 145:1048.
43. Koning, H., M. R. M. Baert, R. De Groot, H. J. Neijens, and H. F. J. Savelkoul. 1995. Analysis of cytokine gene expression in stimulated T cells in small children by semi-quantitative PCR. Med. Inflamm. 4:196.
44. Mullis, K. B. 1991. The polymerase chain reaction in an anemic mode: how to avoid cold oligodeoxyribonuclear fusion. PCR Methods Appl. 1:1.
45. Sambrook, J., E. F. Fritsch, and T. Maniatis, eds. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
46. Uyemura, K., M. Yamamura, D. F. Fivenson, R. L. Modlin, and B. J. Nickoloff. 1993. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J. Invest. Dermatol. 101:701.
47. Anttila, H. S., S. Reitamo, P. Erkko, A. Miettinen, L. Didierjean, and J-H. Saurat. 1990. Membrane and cytosolic interleukin-1 alpha and beta in normal human epidermal cells: variability of epitope exposure in immunohistochemistry. J. Invest. Dermatol. 95:31.
48. Maruyama, K., J. Z. Zhang, Y. Nihei, I. Ono, and F. Kaneko. 1995. Regulatory effects of antipsoriatic agents on interleukin-1 alpha production by human keratinocytes stimulated with gamma interferon in vitro. Skin Pharmacol. 8:41.
49. Bata-Csorgo, Z. S., C. Hammerberg, J. J. Voorhees, and K. D. Cooper. 1995. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture: cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J. Clin. Invest. 95:317.
50. Symons, J. A., P. R. Young, and G. W. Duff. 1995. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 92:1714.
51. Bossù, P., U. Visconti, P. Ruggiero, G. Macchia, M. Muda, R. Bertini, C. Bizzarri, A. Colagrande, V. Sabbatini, G. Maurizi, E. Delgrosso, A. Tagliabue, and D. Boraschi. 1995. Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1. Am. J. Pathol. 147:1852.
52. Gruaz-Chatellard, D., C. Baumberger, J-H. Saurat, and J-M. Dayer. 1991. Interleukin 1 receptor antagonist in human epidermis and cultured keratinocytes. FEBS Lett. 294:137.
53. Blanton, R. A., T. S. Kupper, J. K. McDougall, and S. K. Dower. 1989. Regulation of interleukin 1 and its receptor in human keratinocytes. Proc. Natl. Acad. Sci. USA 86:1273.
54. Arend, W. P. 1993. Interleukin-1 receptor antagonist. Adv. Immunol. 54:167.
55. Sims, J., M. Gayle, J. Slack, M. Alderson, T. Bird, J. Giri, F. R. Colotta, A. Mantovani, K. Shanebeck, K. Grabstein, and S. Dower. 1993. Interleukin-1 signaling occurs exclusively via the type 1 receptor. Proc. Natl. Acad. Sci. USA 90:6155.
56. Schmid, P., D. Cox, G. K. McMaster, and P. Itin. 1993. In situ hybridization analysis of cytokine, proto-oncogene and tumour suppressor gene expression in psoriasis. Arch. Dermatol. Res. 285:334.
57. Malyak, M., M. F. Smith Jr., K. R. Hance, S. K. Dower, and W. P. Arend. 1996. Characterization of a novel, low molecular weight, intracellular form of IL-1 receptor antagonist (IL-1ra). Eur. Cytokine Netw. 7:658 (Abstr.).
58. Auron, P. E., and A. C. Webb. 1994. Interleukin-1: gene expression system regulated at multiple levels. Eur. Cytokine Netw. 5:573.
59. Ohta, Y., I. Katayama, T. Funato, H. Yokozeki, S. Nishiyama, T. Hirano, T. Kishimoto, and K. Nishioka. 1991. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions. Arch. Dermatol. Res. 283:351.
60. Yoshinaga, Y., M. Higaki, S. Terajima, E. Ohkubo, T. Nogita, N. Miyasaka, and M. Kawashima. 1995. Detection of inflammatory cytokines in psoriatic skin. Arch. Dermatol. Res. 287:158.